Mawer Investment Management Ltd. lessened its stake in shares of Cencora, Inc. (NYSE:COR – Free Report) by 5.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 618,284 shares of the company’s stock after selling 32,387 shares during the period. Cencora accounts for 1.2% of Mawer Investment Management Ltd.’s portfolio, making the stock its 24th largest holding. Mawer Investment Management Ltd. owned 0.32% of Cencora worth $208,825,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Oakworth Capital Inc. acquired a new position in Cencora during the fourth quarter valued at approximately $26,000. Elyxium Wealth LLC acquired a new position in Cencora during the fourth quarter valued at approximately $27,000. Archer Investment Corp grew its holdings in Cencora by 134.3% during the fourth quarter. Archer Investment Corp now owns 82 shares of the company’s stock valued at $28,000 after purchasing an additional 47 shares during the last quarter. IAG Wealth Partners LLC acquired a new position in Cencora during the third quarter valued at approximately $30,000. Finally, Caitlin John LLC acquired a new position in Cencora during the third quarter valued at approximately $31,000. Institutional investors and hedge funds own 97.52% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities analysts have commented on COR shares. Barclays increased their price target on Cencora from $400.00 to $425.00 and gave the company an “overweight” rating in a report on Friday, February 13th. Morgan Stanley set a $342.00 price objective on shares of Cencora in a research note on Friday, May 8th. Leerink Partners restated an “outperform” rating on shares of Cencora in a research note on Tuesday, March 17th. Weiss Ratings downgraded shares of Cencora from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday, May 22nd. Finally, William Blair initiated coverage on shares of Cencora in a research note on Tuesday, April 28th. They issued a “market perform” rating on the stock. Twelve equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $380.25.
Cencora Stock Down 1.6%
COR opened at $265.09 on Tuesday. Cencora, Inc. has a fifty-two week low of $244.82 and a fifty-two week high of $377.54. The company has a debt-to-equity ratio of 3.40, a current ratio of 0.95 and a quick ratio of 0.59. The firm’s fifty day moving average price is $297.22 and its two-hundred day moving average price is $332.99. The company has a market capitalization of $51.58 billion, a P/E ratio of 20.33, a P/E/G ratio of 1.24 and a beta of 0.59.
Cencora (NYSE:COR – Get Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). The company had revenue of $78.36 billion for the quarter, compared to the consensus estimate of $81.09 billion. Cencora had a net margin of 0.78% and a return on equity of 135.20%. The firm’s revenue was up 3.9% compared to the same quarter last year. During the same period in the previous year, the business posted $4.42 earnings per share. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, analysts anticipate that Cencora, Inc. will post 17.79 EPS for the current year.
Cencora Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were issued a dividend of $0.60 per share. The ex-dividend date of this dividend was Friday, May 15th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.9%. Cencora’s dividend payout ratio (DPR) is presently 18.40%.
Cencora declared that its Board of Directors has initiated a share buyback plan on Thursday, May 21st that authorizes the company to buyback $2.00 billion in shares. This buyback authorization authorizes the company to repurchase up to 3.9% of its shares through open market purchases. Shares buyback plans are typically an indication that the company’s board believes its shares are undervalued.
Cencora Company Profile
Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.
Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.
Recommended Stories
- Five stocks we like better than Cencora
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Receive News & Ratings for Cencora Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cencora and related companies with MarketBeat.com's FREE daily email newsletter.
